Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Millennium Management LLC reported a 6.00% stake in Ars Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 27, 2026 · Filed Mar 31, 2026
Millennium Management LLC reported a 6.00% stake in Ars Pharmaceuticals, Inc., 5,916,030 shares, as a passive investor on Mar 27, 2026. Filed Mar 31, 2026 (Schedule 13G/A).
- Stake
- 6.00%
- Shares
- 5,916,030
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 5.20% | 5,194,497 |
| Millennium Management LLC | 6.00% | 5,916,030 |
| Millennium Group Management LLC | 6.00% | 5,916,030 |
| Israel A. Englander | 6.00% | 5,916,030 |
Source
Related
- Ars Pharmaceuticals, Inc.
- Millennium Management LLC
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Schedule 13G · Millennium Management LLC · Mar 24, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026